Northland Capmk Predicts Hyliion’s Q1 Earnings (NYSE:HYLN)

Hyliion Holdings Corp. (NYSE:HYLN) – Stock analysts at Northland Capmk issued their Q1 2025 EPS estimates for shares of Hyliion in a report issued on Tuesday, November 19th. Northland Capmk analyst E. Jackson expects that the company will post earnings of ($0.07) per share for the quarter. Northland Capmk currently has a “Hold” rating on the stock. The consensus estimate for Hyliion’s current full-year earnings is ($0.29) per share. Northland Capmk also issued estimates for Hyliion’s Q2 2025 earnings at ($0.08) EPS, Q3 2025 earnings at ($0.08) EPS, Q4 2025 earnings at ($0.09) EPS, FY2025 earnings at ($0.32) EPS, Q1 2026 earnings at ($0.09) EPS, Q2 2026 earnings at ($0.08) EPS, Q3 2026 earnings at ($0.08) EPS, FY2026 earnings at ($0.34) EPS and FY2027 earnings at ($0.30) EPS.

Separately, Northland Securities raised their price target on Hyliion from $1.50 to $2.00 and gave the stock a “market perform” rating in a research report on Tuesday, August 13th.

Hyliion Stock Up 26.6 %

NYSE HYLN opened at $3.68 on Wednesday. The firm has a market cap of $639.59 million, a price-to-earnings ratio of -9.96 and a beta of 1.91. The company has a 50-day simple moving average of $2.49 and a two-hundred day simple moving average of $2.02. Hyliion has a 12-month low of $0.55 and a 12-month high of $3.80.

Insider Activity

In other news, Director Jeffrey A. Craig acquired 50,000 shares of the business’s stock in a transaction on Wednesday, November 20th. The shares were acquired at an average cost of $2.95 per share, with a total value of $147,500.00. Following the transaction, the director now owns 282,060 shares in the company, valued at $832,077. The trade was a 21.55 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Govindaraj Ramasamy bought 30,000 shares of the stock in a transaction dated Wednesday, September 11th. The stock was purchased at an average price of $1.92 per share, with a total value of $57,600.00. Following the purchase, the insider now owns 298,000 shares in the company, valued at $572,160. This trade represents a 11.19 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 20.40% of the company’s stock.

Institutional Investors Weigh In On Hyliion

Several hedge funds have recently bought and sold shares of HYLN. Vanguard Group Inc. grew its stake in shares of Hyliion by 11.7% in the 1st quarter. Vanguard Group Inc. now owns 7,291,480 shares of the company’s stock worth $12,833,000 after buying an additional 762,909 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Hyliion by 9.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 104,086 shares of the company’s stock valued at $184,000 after acquiring an additional 8,580 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Hyliion by 9.9% in the second quarter. Bank of New York Mellon Corp now owns 574,988 shares of the company’s stock worth $931,000 after purchasing an additional 51,794 shares during the last quarter. HITE Hedge Asset Management LLC bought a new position in Hyliion during the 2nd quarter valued at about $656,000. Finally, AQR Capital Management LLC purchased a new stake in Hyliion in the second quarter worth approximately $40,000. Institutional investors own 22.81% of the company’s stock.

Hyliion Company Profile